MBX Biosciences develops peptide-based drug candidates for endocrine and metabolic disorders, including a lead treatment for a rare hormone disorder. It last closed at $49.55 on Nov 20, down 7.23% on the day. The next earnings report for MBX is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, MBX reported EPS of -$1.29. Over its last 8 reports the stock moved an average of 5.8% the session after earnings. Over the last 12 months MBX insiders bought $526K of stock on the open market and sold $3.0M, according to SEC Form 4 filings.
AI Auto Pilots
Is MBX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MBX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on MBXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
MBX · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 8% below its 20 day and 11% below its 50 day average. It is 6% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $47.80, and the nearest resistance the Pivot at $51.11.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 7.7%/day
Key levels
$72.6452 week high+46.6%
$59.22100 day average+19.5%
$56.20Swing high (Oct 21)+13.4%
$54.8850 day average+10.8%
$53.5320 day average+8.0%
$52.87Pivot R1+6.7%
$51.11Pivot+3.1%
$49.55Last close
$47.80Pivot S1−3.5%
$47.60Swing low (Oct 14)−3.9%
$46.69200 day average−5.8%
$26.0052 week low−47.5%
Indicators
RSI (14)
41.00
Middle of its range
Neutral
MACD
-0.50
Below its signal line
Bearish
Stochastic
41.6
Middle of its range
Neutral
ADX (14)
13.2
No clear trend
Williams %R
-81.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-99.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−3.5%
Change over 10 sessions
Bearish
ATR (14)
$3.83
Typical daily range, 7.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityLow, 15.4%/day
Key levels
$72.6452 week high+46.6%
$59.22100 day average+19.5%
$56.20Swing high (Oct 21)+13.4%
$54.8850 day average+10.8%
$53.5320 day average+8.0%
$52.87Pivot R1+6.7%
$51.11Pivot+3.1%
$49.55Last close
$47.80Pivot S1−3.5%
$47.60Swing low (Oct 14)−3.9%
$46.69200 day average−5.8%
$26.0052 week low−47.5%
Indicators
RSI (14)
47.85
Middle of its range
Neutral
MACD
2.04
Below its signal line
Bearish
Stochastic
20.7
Middle of its range
Neutral
ADX (14)
35.0
Trending up
Williams %R
-90.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-96.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−16.1%
Change over 10 sessions
Bearish
ATR (14)
$7.61
Typical daily range, 15.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for MBX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MBX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for MBXHow many large options trades hit MBX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in MBX in the last 90 days.
From SEC Form 4 filings by MBX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MBX is in one of them and how their past MBX trades turned out.
MBX Biosciences is a biopharmaceutical company based in Carmel, Indiana, that develops peptide medicines for hormone and metabolic conditions. Its candidates are built on a proprietary platform designed to give peptides longer action and steadier levels in the body, so they can be taken less often. The lead candidate targets chronic hypoparathyroidism, a rare hormone disorder. The company is also developing treatments for obesity and for low blood sugar after weight loss surgery. Its candidates are still in development, and its intended users are patients with these conditions.